Associate Research Scientist

Dawn Goddard-Eckrich

Dr. Dawn Goddard-Eckrich, EdD, MSS, has three primary areas of research, including: 1) designing, testing and disseminating HIV/STI prevention and health promoting interventions, 2) Community Participatory Research (CBPR) approaches to address health disparities, social determinants and equity related to health risks, access to care, and health related outcomes among minority populations. and 3) the cultural adaptation and of evidence-based interventions aimed at reducing HIV, IPV, substance abuse and wellness interventions.

As Associate Director with the Social Intervention Group (SIG), she is currently leading studies on 1) examine disparities in Medication for Opioid Use Disorder (MOUD) Naloxone/Narcan and the availability of COVID-19 testing/vaccine among pharmacies in upstate New York, within the NIDA-funded HEALing Communities Study (HCS); 2) Using a reproductive justice framework the study Centering reproductive justice within COVID-19 vaccine distribution will be promoting vaccine choice in pregnancy among Black pregnant and lactating people in NYC; 3) Culturally adapting an evidence-based intervention to help reduce Opioid deaths among African Americans under community supervision in New York City.

Dr. Goddard-Eckrich holds a doctorate in Health and Behavioral studies from Teacher’s College, Columbia University (2017). A Master’s degree in Social Sciences from University of Colorado, Denver (2000) and BA in Journalism from CUNY (1998).